Kimbell Royalty Partners, LP KRP 深 滬
等待開盤 08-02 09:30:00 美东时间
14.715
-0.155
-1.04%
華盛通- 最 高14.885
- 今 開14.85
- 成交量 21.37万股
- 最 低 14.6046
- 昨 收 14.87
- 總市值 13.74亿
- 52周最高 15.72
- 市盈率 靜 --
- 換手率 0.23%
- 52周最低 10.51
- 委 比 98.02%
- 總股本 9339.65万
- 歷史最高 15.72
- 量 比 0.72
- 振 幅 1.89%
- 歷史最低 -4.35
- 每 手 1
- 風險率 1.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kropz Plc Issues Director Disclosure Update
The latest announcement is out from Kropz Plc ( ($GB:KRPZ) ). Kropz Plc has iss...
07-30 23:38
Kropz Plc Extends Legal Stay on Cominco Litigation
Kropz Plc ( ($GB:KRPZ) ) has issued an update. Kropz Plc has announced an exten...
07-22 22:07
Kropz Plc Secures ZAR 200 Million Loan Amid Production Challenges
An announcement from Kropz Plc ( ($GB:KRPZ) ) is now available. Kropz Plc has a...
07-15 00:08
Kimbell Royalty Partners shares are trading higher after the company reported a Q1 EPS beat.
Kimbell Royalty Partners shares are trading higher after the company reported a...
05-08 21:03
Kimbell Royalty Partners Q1 EPS $0.20 Beats $0.12 Estimate, Sales $84.21M Miss $84.41M Estimate
Kimbell Royalty Partners (NYSE:KRP) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.12 by 66.67 percent. This is a 400 percent increase over earnings of $0.04 per share from
05-08 19:02
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
美股大行评级 | 潜在涨幅3020.12%！Ascendiant Capital上调Plus Therapeutics目标价至20美元，维持"买入"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
04-22 08:41
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
Viper Energy started at Outperform at Mizuho, citing edge from alliance with Diamondback
Viper Energy (NASDAQ:VNOM) +2.2% in Monday's trading as Mizuho initiates coverage with an Outperform rating and $56 price target, citing its "distinct advantage" given its alignment with Diamondback E...
04-01 02:57
市场巨震下的黄金洼地！KeyBanc深度挖掘抗关税“深度折价”美股
KeyBanc近日精选了一批“深度折价”股票，这些股票在近期市场抛售中展现出吸引力，且相对不受特朗普总统关税政策的影响，拥有经济韧性较强的商业模式。
03-18 10:55
